Researchers at University of California San Diego and Yale University have identified small nuclear RNA base editing as a safer alternative to the widely used CRISPR editing system, addressing concerns about off-target damage. Parallel advances include engineered Cas9 proteins that dramatically reduce the error rate of prime editing, signaling considerable progress in precision genome editing with implications for treating genetic diseases.